Efficacy and safety of booster vaccination against SARS-CoV-2 in dialysis and renal transplant patients: systematic review and meta-analysis

S Taheri - International Urology and Nephrology, 2023 - Springer
Introduction Patients under renal replacement therapy are at an increased risk of severe
infection with SARS-CoV-2, and have been known to have impaired response to standard …

COVID-19 in kidney transplantation-implications for immunosuppression and vaccination

L Kodali, P Budhiraja, J Gea-Banacloche - Frontiers in Medicine, 2022 - frontiersin.org
COVID-19 pandemic continues to challenge the transplant community, given increased
morbidity and mortality associated with the disease and poor response to prevention …

Executive summary of the consensus statement of the group for the study of infection in transplantation and other immunocompromised host (GESITRA-IC) of the …

S Herrera, JM Aguado, FJ Candel, E Cordero… - Transplantation …, 2023 - Elsevier
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) arose in December 2019
in China rapidly evolving to the Coronavirus Disease 2019 (COVID-19) pandemic. Since …

Safety and efficacy of one and two booster doses of SARS‐CoV‐2 mRNA vaccines in kidney transplant recipients: A randomized clinical trial

P Drenko, M Kacer, L Kielberger, T Vlas… - Transplant Infectious …, 2023 - Wiley Online Library
Background Kidney transplant recipients are at risk for a severe course of COVID‐19 with a
high mortality rate. A considerable number of patients remains without a satisfactory …

[HTML][HTML] Immunogenicity and Safety of the Three-Dose COVID-19 Vaccine Regimen in Patients Receiving Renal Replacement Therapy: A Systematic Review and …

BM Ma, AR Tam, KW Chan, IFN Hung, SCW Tang… - Kidney …, 2024 - karger.com
Background: A three-dose regimen is the current standard for COVID-19 vaccination, but
systematic data on immunogenicity and safety in chronic kidney disease patients remains …

Factors associated with vaccine-induced T-cell immune responses against severe acute respiratory syndrome coronavirus 2 in kidney transplant recipients

I Tometten, S Landmann, M Kantauskaite… - The Journal of …, 2023 - academic.oup.com
Vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an
important prophylactic measure in kidney transplant recipients (KTRs), but the immune …

Factors associated with vaccine-induced T cell immune responses against SARS-CoV-2 in kidney transplant recipients.

I Tometten, S Landmann… - Journal of Infectious …, 2023 - search.ebscohost.com
Vaccination against SARS-CoV-2 is an important prophylactic measure in kidney transplant
recipients (KTRs), however, the immune response is often impaired. Here, we examined the …

A systematic review and meta-analysis of the seroconversion rates and adverse effects of COVID-19 mRNA vaccine and COVID-19 viral vector vaccine in kidney …

S Chen, W Wei, F Huang, J Wang, X Li… - Human Vaccines & …, 2023 - Taylor & Francis
Patients received kidney transplantation (KTR) have a low seroconversion rate after
vaccination. Our objective was to compare the seroconversion rates and adverse effects of …

Comparison of BNT162b2 and mRNA1273 vaccines in solid organ transplant recipients: Post‐Hoc analysis of a Japanese national prospective study

M Yoshikawa, Y Natori, R Oki… - Scandinavian …, 2023 - Wiley Online Library
Abstract The coronavirus disease‐19 (COVID‐19) vaccine efficacy and immunogenicity in
the immunocompetent population are well established. However, in solid organ transplant …

Infekční nemoci a jejich vliv na rozvoj a progresi dysfunkce renálního štěpu

P Drenko - 2024 - dspace.cuni.cz
Infekční nemoci a jejich vliv na rozvoj a progresi dysfunkce renálního štěpu Infekční
onemocnění představují významný rizikový faktor morbidity a mortality příjemců orgánových …